About us
News
Nordic Pharma joins the Pharmaceutical Supply Chain Initiative
-
We are pleased to announce that Nordic Pharma has joined…
Draupnir Holdings Ltd have officially merged with Nordic Group B.V
-
We are pleased to announce that as of January 2023,…
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
-
Canada, March 29, 2022 – NORDIC PHARMA, a SEVER Life…
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
-
Paris, January 2022 – Nordic Pharma is pleased to announce…
European Commission approves Teysuno in metastatic colorectal cancer
-
Nordic Pharma announces that on the 24th of January, the…
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
-
Nordic Pharma has announced that on 16 December 2021, the…
Nordic Pharma present at CPhI !
-
Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November…
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
-
Nordic Pharma AAP is pleased to announce that the Nordixate®…
Nordimet® PFS and Pen are launched in Chile!
-
Nordic Pharma Americas, Asia, Pacific are pleased to announce that…
About Our Portfolio